Free Trial

IDEXX Laboratories (IDXX) News Today

$496.95
-2.82 (-0.56%)
(As of 05/31/2024 ET)
Rathbones Group PLC Sells 144,725 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Rathbones Group PLC decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 64.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 78,258 shares of the company's stock after selling 144,725 shares during the period.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Holdings Reduced by Axiom Investors LLC DE
Axiom Investors LLC DE cut its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 54.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,879 shares of the company's stock
Roundview Capital LLC Acquires Shares of 3,184 IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Roundview Capital LLC acquired a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,184 shares of the company's stock, va
Comgest Global Investors S.A.S. Buys 3,065 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Comgest Global Investors S.A.S. raised its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,020 shares of the company's st
Dynamic Technology Lab Private Ltd Sells 2,154 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Dynamic Technology Lab Private Ltd cut its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 76.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 674 shares of the company's stock a
Quantum Capital Management LLC NJ Buys 16,787 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Quantum Capital Management LLC NJ lifted its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 90.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,438 shares
Dai ichi Life Insurance Company Ltd Sells 3,224 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Dai ichi Life Insurance Company Ltd lessened its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 24.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,063 shares of the company's stock after selling 3,224
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at StockNews.com
StockNews.com upgraded shares of IDEXX Laboratories from a "hold" rating to a "buy" rating in a research report on Wednesday.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Position Decreased by GW&K Investment Management LLC
GW&K Investment Management LLC cut its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,464 shares of the company's stock aft
IDEXX Laboratories Q1 Earnings Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by Corient Private Wealth LLC
Corient Private Wealth LLC grew its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 7.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 142,595 shares of the
Simplicity Wealth LLC Buys Shares of 3,353 IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Simplicity Wealth LLC bought a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,353 shares of the company's stock, valued at approximately $1,810,000. Severa
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Bruce L. Claflin Sells 200 Shares
IDEXX Laboratories, Inc. (NASDAQ:IDXX - Get Free Report) Director Bruce L. Claflin sold 200 shares of the stock in a transaction on Friday, May 17th. The stock was sold at an average price of $540.80, for a total value of $108,160.00. Following the completion of the sale, the director now owns 161 shares in the company, valued at approximately $87,068.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
ING Groep NV Purchases 18,048 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
ING Groep NV boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 2,978.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,654 shares of the company's stock af
Fiera Capital Corp Boosts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Fiera Capital Corp increased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 39.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 126,633 shares of the company's stock after purchasing a
Mitsubishi UFJ Asset Management Co. Ltd. Buys 6,240 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 7.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 90,292 shares of the company's stock after acquiring a
IDEXX Laboratories (NASDAQ:IDXX) Upgraded to "Buy" at StockNews.com
StockNews.com upgraded IDEXX Laboratories from a "hold" rating to a "buy" rating in a report on Tuesday.
Torray Investment Partners LLC Reduces Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Torray Investment Partners LLC lowered its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 95.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 384 shares of the company's stock after selling 9,008 shares during the quarter. T
IDEXX Laboratories (NASDAQ:IDXX) PT Lowered to $596.00
Morgan Stanley decreased their price target on IDEXX Laboratories from $620.00 to $596.00 and set an "overweight" rating on the stock in a research note on Tuesday.
1,577 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Purchased by Principal Securities Inc.
Principal Securities Inc. purchased a new stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,577 shares of the company's stock, valued at approximately $875,000. Severa
Principal Financial Group Inc. Cuts Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Principal Financial Group Inc. decreased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 781,368 shares of the company's stock after selling 34,495 shares during the
Geneva Capital Management LLC Has $31 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Geneva Capital Management LLC lowered its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 55,842 shares of the company's stock after selling 1,
Apollon Wealth Management LLC Increases Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Apollon Wealth Management LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 35.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,116 shares of the company's stock afte
Spire Wealth Management Boosts Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Spire Wealth Management boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 46.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,328 shares of the company's stock after buying an addi
TCG Advisory Services LLC Acquires New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
TCG Advisory Services LLC bought a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 43,518 shares of the company's stock, valued at approximately $24,155,000. IDEXX L
Swiss National Bank Has $144.09 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Swiss National Bank reduced its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 259,600 shares of the company's stock after selling 7,500 shares during th
Q2 2024 EPS Estimates for IDEXX Laboratories, Inc. (NASDAQ:IDXX) Lowered by William Blair
IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) - Equities researchers at William Blair decreased their Q2 2024 earnings estimates for IDEXX Laboratories in a report released on Wednesday, May 1st. William Blair analyst R. Daniels now expects that the company will post earnings per share of
Van ECK Associates Corp Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Van ECK Associates Corp lifted its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 16.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,293 shares of the company's stock after
IDEXX Laboratories (NASDAQ:IDXX) PT Lowered to $570.00 at Barclays
Barclays reduced their target price on shares of IDEXX Laboratories from $655.00 to $570.00 and set an "overweight" rating on the stock in a research report on Thursday.
Q4 2024 Earnings Estimate for IDEXX Laboratories, Inc. (NASDAQ:IDXX) Issued By William Blair
IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) - Research analysts at William Blair cut their Q4 2024 earnings per share (EPS) estimates for shares of IDEXX Laboratories in a research report issued to clients and investors on Wednesday, May 1st. William Blair analyst R. Daniels now anticipa
Q1 2024 IDEXX Laboratories Inc Earnings Call
IDEXX Laboratories (NASDAQ:IDXX) Shares Gap Down to $492.76
IDEXX Laboratories (NASDAQ:IDXX) Shares Gap Down to $492.76
Idexx 1Q Net Up; Lowers Guidance for The Year
Get IDEXX Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.

IDXX Media Mentions By Week

IDXX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IDXX
News Sentiment

1.26

0.76

Average
Medical
News Sentiment

IDXX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IDXX Articles
This Week

8

8

IDXX Articles
Average Week

Get IDEXX Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IDXX) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners